Pricing Log in Create free account

InflaRx N.V. (IFRX) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

InflaRx N.V. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. InflaRx N.V. and Zentalis Pharmaceuticals, Inc. are of similar size ($212.2M and $212.1M). Across the 10 metrics below, InflaRx N.V. leads on 7 and Zentalis Pharmaceuticals, Inc. on 3.

Valuation

Metric IFRX ZNTL Biotechnology median
P/E n/m n/m 8.50
P/S 5,075.70 n/m 9.71
P/B 0.91 1.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.71 0.15 0.64
EV/Sales (1,061.22) n/m 9.21
Earnings yield (43.94%) (91.55%) (33.15%)
Free cash flow yield (17.60%) (84.25%) (25.50%)

Profitability

Metric IFRX ZNTL Biotechnology median
Gross margin (26,762.42%) 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (38.71%) (66.75%) (56.36%)
Return on assets (32.75%) (49.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IFRX ZNTL Biotechnology median
Revenue growth (TTM) (83.39%) — 6.02%
EPS growth (last fiscal year) 9.41% 18.03% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IFRX ZNTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.22 4.82 4.72
Net debt to EBITDA 0.97 1.59 0.96

Dividend

Metric IFRX ZNTL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IFRX ZNTL Biotechnology median
Market cap 212.21m 212.07m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack